Rita Shaknovich transitioned from surgery to pathologist and physician scientist.
Focused on simplifying complex workflows in molecular diagnostics.
Advocates for decentralized access to diagnostic tools.
Highlights the role of AI in transforming diagnostics interpretation.
Emphasizes the need for more research funding for rare and chronic diseases.
Supports the use of liquid biopsies and multi-omics technologies.
Stresses the importance of addressing healthcare reimbursement complexities.
Industry Insights: Pride in Precision Medicine
Rita Shaknovich, Chief Medical Officer at Agilent Technologies, shares her insights into automation, access, and analytics
10/21/2025
Interview
5 min read
